Treatment failures and secondary resistance to antibiotics.: A growing concern in Helicobacter pylori therapy

被引：20
作者：
de Boer, WA
Borody, TJ
机构：
[1] Hosp Bernhoven, Dept Internal Med, NL-5340 BE Oss, Netherlands
[2] Ctr Digest Dis, Five Dock, Australia
来源：
DIGESTIVE AND LIVER DISEASE | 2000年 / 32卷 / 08期
关键词：
D O I：
10.1016/S1590-8658(00)80328-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：673 / 675
页数：3
相关论文
共 31 条
[1]  
Borody TJ, 2000, HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, P623
[2]  
Broutet N, 2000, GUT, V47, pA102
[3]   Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance [J].
Buckley, MJM ;
Xia, HX ;
Hyde, DM ;
Keane, CT ;
OMorain, CA .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (10) :2111-2115
[4]  
Calvet X, 2000, ALIMENT PHARM THER, V14, P603
[5]  
Canena JM, 1999, GASTROENTEROLOGY, V116, pA131
[6]   Regular review -: Treatment of Helicobacter pylori infection [J].
de Boer, WA ;
Tytgat, GNJ .
BRITISH MEDICAL JOURNAL, 2000, 320 (7226) :31-34
[7]  
De Boer WA, 2000, HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, P609
[8]  
Gisbert JP, 2000, GUT, V47, pA104
[9]  
Goddard AF, 1997, GUT, V41, pA96
[10]   Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy [J].
Heep, M ;
Kist, M ;
Strobel, S ;
Beck, D ;
Lehn, N .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (07) :538-541
1234